tmem223 Antibody

What is TMEM223 and why is it important in mitochondrial research?

TMEM223 is an integral protein of the inner mitochondrial membrane (IMM) with two transmembrane spans. Its N- and C-termini face the mitochondrial matrix. TMEM223 functions as a mitochondrial ribosome-associated protein involved in the biogenesis of respiratory chain complex IV (cytochrome c oxidase). Its importance lies in its role in stimulating the translation of COX1 mRNA and participating in early COX1 assembly intermediates. Research has shown that TMEM223 knockout cells exhibit reduced cytochrome c oxidase activity (approximately 62.5% of wild-type), demonstrating its significance in mitochondrial function .

What epitopes are typically targeted by TMEM223 antibodies?

TMEM223 antibodies are commonly directed against the C-terminus of the protein. This targeting strategy is particularly effective because the C-terminus of TMEM223 is exposed to the mitochondrial matrix, making it accessible for antibody binding in various experimental applications. In published research, antibodies against the C-terminus have successfully detected both the full-length protein and fragments generated during protease treatment, such as the faster migrating C-terminal fragment observed after Proteinase K treatment of mitoplasts .

What are the typical molecular weight and band patterns observed when using TMEM223 antibodies in western blotting?

When using TMEM223 antibodies for western blotting, researchers should expect to detect the full-length protein as well as potential fragments depending on the experimental conditions. After Proteinase K treatment of mitoplasts, a faster migrating C-terminal fragment of TMEM223 is detected, which represents the second transmembrane domain and the C-terminus of the protein . The exact molecular weight can vary depending on post-translational modifications and experimental conditions. Researchers should validate band patterns in their specific experimental system, particularly when comparing wild-type cells to TMEM223 knockout or knockdown models.

How can TMEM223 antibodies be used to study mitochondrial ribosome interactions?

TMEM223 antibodies can be employed in co-immunoprecipitation experiments to investigate interactions between TMEM223 and mitochondrial ribosomal proteins. In published research, TMEM223 has been detected in eluates alongside ribosomal proteins uL1m and uS14m, confirming its association with the mitochondrial ribosome . Researchers can use TMEM223 antibodies in reciprocal immunoprecipitations, where either TMEM223 or ribosomal components are targeted, to verify these interactions. Additionally, proximity labeling techniques combined with TMEM223 antibodies for validation can map the precise interaction sites between TMEM223 and the ribosomal complex.

What experimental approaches can be used to study TMEM223's role in complex IV biogenesis using TMEM223 antibodies?

Several experimental approaches can leverage TMEM223 antibodies to investigate its role in complex IV biogenesis:

• Immunoprecipitation with early assembly factors: TMEM223 antibodies can be used alongside antibodies against early COX1 assembly intermediates (MITRAC complexes), such as C12ORF62 (COX14) and MITRAC12 (COA3), to study their interactions. Research has shown that TMEM223 is recovered in the eluate of C12ORF62 FLAG and MITRAC12 FLAG purifications .

• BN-PAGE analysis: Following immunoprecipitation with TMEM223 antibodies, blue native PAGE can separate intact protein complexes to identify which assembly intermediates contain TMEM223. This approach has revealed that TMEM223 is predominantly found in early assembly intermediates rather than later stage complexes .

• Pulse-chase experiments: Combining [35S]methionine labeling with immunoprecipitation using TMEM223 antibodies can track the assembly kinetics of newly synthesized mitochondrial proteins into respiratory complexes, revealing how TMEM223 influences this process.

How can TMEM223 antibodies be used for immunofluorescence microscopy to study its submitochondrial localization?

For immunofluorescence microscopy, cells should first be fixed using an 8% formaldehyde solution and permeabilized with 0.25% Triton X-100, followed by blocking with 5% BSA solution . TMEM223 antibodies can then be applied to visualize the protein's localization within mitochondria. To confirm submitochondrial localization, co-staining with markers for different mitochondrial compartments (outer membrane, intermembrane space, inner membrane, matrix) is recommended. Since TMEM223 is an integral protein of the inner mitochondrial membrane with its N- and C-termini facing the matrix, researchers should expect a distinct staining pattern that colocalizes with inner membrane markers but shows a unique distribution pattern compared to matrix proteins.

What controls should be included when using TMEM223 antibodies for western blotting and immunoprecipitation?

When using TMEM223 antibodies, researchers should include the following controls:

• Positive control: Wild-type cells or tissues known to express TMEM223

• Negative control: TMEM223 knockout cells (TMEM223-/-) or TMEM223 siRNA-depleted cells

• Antibody specificity control: Pre-incubation of the antibody with a competing peptide

• Loading control: Mitochondrial proteins such as TOM20 (outer membrane) or ATP5B (inner membrane) to normalize TMEM223 levels

• Fractionation controls: Markers for different mitochondrial compartments in submitochondrial localization studies

In knockout validation studies, researchers have verified TMEM223 antibody specificity by confirming the absence of signal in TMEM223-/- cell lines, which displayed premature stop codons at positions encoding amino acids 36 and 38 .

What methodological approaches are most effective for studying TMEM223 protein interactions using antibodies?

Based on published research, several methodological approaches have proven effective:

• Immunoprecipitation for protein interaction studies: Using either endogenous TMEM223 antibodies or antibodies against tagged versions (e.g., FLAG-tagged TMEM223) to pull down protein complexes. This approach has successfully identified interactions with mitochondrial ribosomal proteins and complex IV assembly factors .

• Crosslinking followed by immunoprecipitation: To capture transient interactions, researchers can apply crosslinking agents before cell lysis and immunoprecipitation with TMEM223 antibodies.

• Blue Native PAGE followed by western blotting: For analyzing intact complexes containing TMEM223, BN-PAGE (using 1% digitonin or 1% DDM for solubilization) followed by western blotting with TMEM223 antibodies helps determine which complexes contain the protein of interest .

• Proximity-based labeling: Combining BioID or APEX2 fusions with TMEM223 validation by antibodies can identify the broader interactome.

How should samples be prepared for optimal detection of TMEM223 using antibodies?

For optimal detection of TMEM223, sample preparation should follow these guidelines:

• Mitochondrial isolation: Isolate mitochondria from cells to enrich for TMEM223, as it is a mitochondrial protein. This concentration step improves detection sensitivity.

• Solubilization conditions: For membrane proteins like TMEM223, proper solubilization is critical. Use 1% digitonin or 1% DDM in appropriate buffer (20 mM Tris-HCl, pH 7.4, 0.1 mM EDTA, 50 mM NaCl, 10% glycerol, 1 mM PMSF) for 20 minutes on ice .

• SDS-PAGE conditions: For standard western blotting, separate proteins using SDS-PAGE and transfer to PVDF membrane by semidry blotting.

• Antibody incubation: Incubate primary TMEM223 antibodies overnight at 4°C or for 1 hour at room temperature, followed by secondary antibody incubation for 1-2 hours at room temperature .

• Detection method: Use enhanced chemiluminescence detection for optimal visualization of TMEM223 bands.

What are common issues encountered when using TMEM223 antibodies and how can they be resolved?

Researchers may encounter several challenges when working with TMEM223 antibodies:

• Weak signal intensity: This may occur due to low expression levels of TMEM223. Solutions include:

  • Using mitochondrial enrichment protocols rather than whole cell lysates

  • Increasing antibody concentration or incubation time

  • Employing more sensitive detection methods (e.g., enhanced chemiluminescence substrates)

  • Optimizing transfer conditions for membrane proteins

• Non-specific bands: To address this issue:

  • Validate antibody specificity using TMEM223 knockout cells as negative controls

  • Optimize blocking conditions (5% BSA is recommended)

  • Adjust antibody dilution and washing stringency

  • Consider using monoclonal antibodies if polyclonal antibodies show high background

• Inconsistent immunoprecipitation results: Improve results by:

  • Optimizing solubilization conditions for this membrane protein

  • Using crosslinking approaches for transient interactions

  • Pre-clearing lysates to reduce non-specific binding

  • Considering native vs. denaturing conditions based on the experimental question

How can researchers distinguish between TMEM223 and similar mitochondrial membrane proteins?

To differentiate TMEM223 from other mitochondrial membrane proteins:

• Size comparison: Use molecular weight standards and known controls to distinguish TMEM223 based on its migration pattern.

• Knockout/knockdown validation: Always include TMEM223 knockout or siRNA-depleted samples as negative controls to confirm antibody specificity.

• Peptide competition assays: Pre-incubate antibodies with the peptide used for immunization to verify signal specificity.

• Mass spectrometry validation: Following immunoprecipitation with TMEM223 antibodies, perform mass spectrometry analysis to confirm protein identity.

• Comparative analysis: When studying multiple mitochondrial proteins simultaneously, use a panel of antibodies against distinct proteins (e.g., SMIM4, C12ORF73) and compare their distribution and behavior in various experimental conditions .

How can TMEM223 antibodies be used to investigate disease-related mitochondrial dysfunction?

TMEM223 antibodies can be valuable tools for studying mitochondrial dysfunction in disease contexts:

• Expression level analysis: Compare TMEM223 levels in patient-derived samples versus healthy controls using western blotting with TMEM223 antibodies.

• Complex IV assembly defects: Since TMEM223 is involved in complex IV biogenesis, researchers can use TMEM223 antibodies to study assembly intermediates in disease models with respiratory chain deficiencies.

• Compensatory mechanisms: As demonstrated in TMEM223 knockout cells, which show increased levels of complex III (approximately 165% of wild-type) , TMEM223 antibodies can help investigate compensatory responses to primary mitochondrial defects.

• Therapeutic intervention monitoring: In models where therapies aim to restore mitochondrial function, TMEM223 antibodies can track changes in protein expression and complex assembly.

• Interaction partner analysis: In disease states, altered interactions between TMEM223 and its partners may occur, which can be detected using co-immunoprecipitation with TMEM223 antibodies.

How can TMEM223 antibodies be integrated into systems biology approaches for studying mitochondrial translation and OXPHOS assembly?

TMEM223 antibodies can be integrated into systems biology approaches through:

• Multi-omics integration: Combine antibody-based detection of TMEM223 with transcriptomics and proteomics data to obtain a comprehensive view of how TMEM223 functions within the broader network of mitochondrial translation and OXPHOS assembly.

• Temporal analysis of assembly: Use TMEM223 antibodies in time-course experiments (e.g., after inhibition and release of mitochondrial translation with thiamphenicol) to map the kinetics of complex IV assembly and how TMEM223 influences this process.

• Network analysis: Through serial immunoprecipitations with TMEM223 antibodies and other components, researchers can construct interaction networks that reveal the hierarchical organization of complex IV assembly.

• Comparative interactomics: Apply TMEM223 antibodies to compare interactome differences between cellular states, tissues, or species to identify conserved and divergent aspects of mitochondrial translation and OXPHOS assembly.

• Mathematical modeling: Use quantitative data obtained with TMEM223 antibodies to inform computational models of mitochondrial translation and OXPHOS assembly.

What are the considerations for using TMEM223 antibodies in tissue-specific or developmental studies of mitochondrial function?

When using TMEM223 antibodies for tissue-specific or developmental studies, researchers should consider:

• Antibody validation across tissues: Verify that the TMEM223 antibody recognizes the protein across different tissue types, as expression levels and potential isoforms may vary.

• Developmental regulation: TMEM223 expression and function might change during development, requiring careful selection of developmental time points and consideration of potential post-translational modifications.

• Tissue-specific interaction partners: The TMEM223 interactome may differ between tissues, requiring tissue-specific immunoprecipitation studies followed by mass spectrometry.

• Fixation and processing protocols: Different tissues may require optimized protocols for fixation, permeabilization, and antibody incubation to achieve optimal TMEM223 detection in immunohistochemistry or immunofluorescence applications.

• Reference genes/proteins: Select appropriate tissue-specific reference genes or proteins for normalization when quantifying TMEM223 levels across tissues or developmental stages.

How can TMEM223 antibodies be used to investigate the relationship between mitochondrial translation and respiratory complex assembly?

TMEM223 antibodies offer unique opportunities to study the coupling between mitochondrial translation and respiratory complex assembly:

• Pulse-chase experiments: Combine [35S]methionine labeling with immunoprecipitation using TMEM223 antibodies to track newly synthesized mitochondrial-encoded proteins and their incorporation into complexes. This approach has revealed that TMEM223 affects specifically COX1 synthesis, showing a significant decrease in newly synthesized COX1 in TMEM223-/- cells .

• Ribosome-nascent chain complex analysis: Use TMEM223 antibodies to study its association with ribosome-nascent chain complexes during co-translational insertion of mitochondrial-encoded proteins into the inner membrane.

• Assembly intermediate characterization: Through sequential immunoprecipitations with TMEM223 antibodies and antibodies against assembly factors such as C12ORF62, MITRAC12, CMC1, and MITRAC7, researchers can map the progression of assembly intermediates and TMEM223's specific role in early stages .

• Translation inhibition studies: Compare TMEM223 interactions before and after inhibition of mitochondrial translation with agents like thiamphenicol to distinguish translation-dependent and independent interactions.

• Structural studies: Combine TMEM223 antibody-based purification with structural biology approaches to determine the three-dimensional organization of TMEM223-containing complexes during various stages of assembly.